Lixivaptan
PA-ADPKD-304
Phase 3 small_molecule terminated
Quick answer
Lixivaptan for Polycystic Kidney Disease, Adult is a Phase 3 program (small_molecule) at Centessa Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Centessa Pharmaceuticals plc
- Indication
- Polycystic Kidney Disease, Adult
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated